We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Roundup: FDA Warns Four Firms for Quality Failures
The item has been added to your shopping cart.
Warning Letter Roundup: FDA Warns Four Firms for Quality Failures
The FDA issued warning letters to two drugmakers and two contract testing facilities for serious quality failures, including testing violations, data integrity lapses and lax environmental monitoring.